These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1429330)

  • 1. Activity of amoxycillin/clavulanic acid against Escherichia coli in vivo--correction.
    Beale AS
    J Antimicrob Chemother; 1992 Jul; 30(1):108. PubMed ID: 1429330
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to amoxicillin/clavulanate in Escherichia coli.
    Colaert J
    Acta Clin Belg; 1992; 47(5):353-4. PubMed ID: 1334324
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance to amoxicillin/clavulanate in Escherichia coli.
    Glupczynski Y; Mac Gillavry G; Yourassowsky E
    Acta Clin Belg; 1992; 47(5):354-5. PubMed ID: 1334325
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of the microbiology of amoxycillin/clavulanic acid over the 15 year period 1978-1993.
    Rolinson GN
    J Chemother; 1994 Oct; 6(5):283-318. PubMed ID: 7861195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989.
    Seetulsingh PS; Hall LM; Livermore DM
    J Antimicrob Chemother; 1991 Jun; 27(6):749-59. PubMed ID: 1938685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of NCCLS, SFM, and DIN breakpoints upon the incidence of co-amoxiclav resistance in Escherichia coli.
    Durodia J; Simpson I
    J Antimicrob Chemother; 1995 Dec; 36(6):1105-6. PubMed ID: 8821615
    [No Abstract]   [Full Text] [Related]  

  • 7. Microcalorimetric, turbidimetric, phase-contrast microscopic, and electron microscopic investigations of the actions of amoxicillin, clavulanic acid and augmentin on amoxicillin-sensitive and amoxicillin-resistant strains of Escherichia coli.
    Semenitz E; Casey PA; Pfaller W; Gstraunthaler G
    Chemotherapy; 1983; 29(3):192-207. PubMed ID: 6347546
    [No Abstract]   [Full Text] [Related]  

  • 8. Activity of amoxycillin-clavulanic acid against Legionella pneumophila in vitro and in an experimental respiratory infection model.
    Smith GM; Sutherland R
    J Hosp Infect; 1992 Nov; 22 Suppl A():61-7. PubMed ID: 1362751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of bactericidal activity for Branhamella catarrhalis of fleroxacin compared with that of amoxycillin-clavulanic acid.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():43-7. PubMed ID: 3144548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of beta-lactamases produced by cephalothin-susceptible Escherichia coli clinical isolates resistant to co-amoxiclav and ticarcillin-clavulanic acid. The CERIB Study Group.
    Chardon H; Farzaneh S; Labia R; Jarlier V; Nicolas MH; Paul G; Poyart C; Sirot D; Sirot J
    J Antimicrob Chemother; 1995 Jul; 36(1):267-9. PubMed ID: 8537279
    [No Abstract]   [Full Text] [Related]  

  • 11. Amoxycillin/clavulanate resistant Escherichia coli.
    Williams H; King A; Shannon K; Phillips I
    Lancet; 1988 Feb; 1(8580):304-5. PubMed ID: 2893121
    [No Abstract]   [Full Text] [Related]  

  • 12. Clavulanate-potentiated amoxycillin: in vitro antibacterial activity and oral bioavailability in calves.
    Soback S; Bor A; Kurtz B; Paz R; Ziv G
    J Vet Pharmacol Ther; 1987 Jun; 10(2):105-13. PubMed ID: 3302313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amoxycillin/clavulanate and Haemophilus influenzae.
    Delmée M; Glupczynski Y; Gordts B; Van Landuyt H; Van Noyen R
    Acta Clin Belg; 1994; 49(6):311-2. PubMed ID: 7871939
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of increase in resistance to quinolones in general practice isolates of Escherichia coli.
    Weber P; Plaisance JJ; Mancy C
    J Antimicrob Chemother; 1994 Jul; 34(1):187-8. PubMed ID: 7961211
    [No Abstract]   [Full Text] [Related]  

  • 15. Amoxycillin/clavulanate resistant Escherichia coli.
    French G; Ling T
    Lancet; 1988 Mar; 1(8587):704. PubMed ID: 2895231
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of bacterial combinations on the post-antibiotic effect].
    Mínguez F; Aparicio P; Lurueña S; Cabronero MJ; Prieto J
    Enferm Infecc Microbiol Clin; 1990 Apr; 8(4):208-12. PubMed ID: 2090206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of enteric pathogens to amoxicillin and clavulanate-potentiated amoxicillin.
    Mégraud F; Gavinet A
    Chemioterapia; 1987 Jun; 6(2 Suppl):75-6. PubMed ID: 3334666
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative activities of amoxycillin, amoxycillin/clavulanic acid and tetracycline against Chlamydia trachomatis in cell culture and in an experimental mouse pneumonitis.
    Beale AS; Faulds E; Hurn SE; Tyler J; Slocombe B
    J Antimicrob Chemother; 1991 May; 27(5):627-38. PubMed ID: 1885420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparison of the in vitro susceptibility of three bacteria to beta-lactamase inhibitors and to ampicillin and cefazolin].
    Acar N; Diri MC; Türkyilmaz FR
    Mikrobiyol Bul; 1987 Oct; 21(4):284-8. PubMed ID: 3332705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality control parameters for broth microdilution susceptibility testing of amoxicillin and amoxicillin-clavulanic acid.
    Barry AL; Allen SD; Fuchs PC; Jorgensen JH; Pfaller MA
    Eur J Clin Microbiol Infect Dis; 1994 Feb; 13(2):186-8. PubMed ID: 8013498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.